Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

1,200+ U2AF1 mutations reveal distinct clinicobiological features of the S34/Q157 co-mutation subgroup

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHaoxu WangJCJiao Chang

Discussion

Loading...

Member takes

Overview

Analyses show U2AF1 S34/Q157 co-mutated myeloid neoplasms exhibit unique characteristics, implicating tumorigenesis mechanisms.

Key Points

  • The research aims to characterize U2AF1 S34/Q157 co-mutated myeloid neoplasms.
  • Evaluated 1,263 patients for U2AF1 mutations using next-generation sequencing.
  • Stratified patients into co-mutated and single-mutant groups for comparison.
  • Conducted comparative analyses of molecular and clinical characteristics.
  • Identified distinct molecular profiles in U2AF1 co-mutated cases vs. single mutants.
  • Noted increased prevalence of AML in the S34/Q157 co-mutated group.
  • Documented unique hematologic features and concomitant mutations in co-mut patients.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da01https://doi.org/10.1182/blood-2025-3499
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice2026 · 1 citations
  2. 2Prevalence, clinical correlates and clonal inferences of concurrent splicing factor mutations in patients with myeloid neoplasms2025
  3. 3An actionable DNA repair defect in myeloid malignancies with U2AF1 S34 mutations2025
  4. 4Additional myelodysplasia-related genes mutations affected the clinical presentations and prognosis of patients with SRSF2/TET2 co-mutations2025
  5. 5Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasms2026